ROR1 and breast cancer: To investigate if ROR1 inhibition could potentiate the cytotoxicity induced by chemo drugs in vitro, we knocked down ROR1 via siRNA (Fig. 2A) and treated BC lines MDA-MB-231 and SUM-159 PT with Doxorubicin and Cisplatin.